A multi-centre, placebo-controlled, double-blind trial to examine the safety and efficacy of pimavanserin in the treatment of psychosis in Parkinson's diseaseJ. H. Friedman,B. Ravina,R. Mills,H. Williams,S. Revell, D. Bahr,F. Tison,D. BurnEUROPEAN JOURNAL OF NEUROLOGY（2009）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
